Results 11 to 20 of about 1,471,694 (149)

Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion [PDF]

open access: yesWorld Journal of Surgical Oncology, 2006
Background Cytoreductive surgery and intraoperative, intraperitoneal hyperthermic chemoperfusion (HIPEC) is increasingly used to treat peritoneal surface metastases.
Stemmerman Grant   +3 more
doaj   +2 more sources

Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases

open access: yesWorld Journal of Surgical Oncology
Background Cytoreductive surgery and chemotherapy reportedly improve the prognosis of patients with metachronous peritoneal metastases. However, the types of peritoneal metastases indicated for cytoreductive surgery remains unclear.
Emi Ota   +6 more
doaj   +2 more sources

Splenectomy during cytoreductive surgery in epithelial ovarian cancer

open access: yesCancer Management and Research, 2018
Hengzi Sun,1 Xiaoning Bi,1 Dongyan Cao,1 Jiaxin Yang,1 Ming Wu,1 Lingya Pan,1 Huifang Huang,1 Ge Chen,2 Keng Shen1 1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union ...
Sun H   +8 more
doaj   +1 more source

Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy by Video-Assisted Surgery for Pleural Malignancies: Technical Aspects and Safety Profile [PDF]

open access: yes, 2021
Background: Pleural malignancies are challenging conditions in terms of possibility of cure. Recent growing interest towards Hyperthermic Intrathoracic Chemotherapy (HITHOC) after Cytoreductive Surgery (CRS) has been referred.
William Grossi   +11 more
core   +1 more source

Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy by Video-Assisted Surgery for Pleural Malignancies. Technical Aspects and Safety Profile from A Single Center [PDF]

open access: yes, 2021
Background Pleural malignancies are challenging conditions in terms of possibility of cure. Recent growing interest towards Hyperthermic Intrathoracic Chemotherapy (HITHOC) after Cytoreductive Surgery (CRS) has been referred.
Londero Francesco   +11 more
core   +1 more source

Implementation of the enhanced recovery after surgery protocol for patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion

open access: yes, 2021
Aim of the study – to investigate the feasibility of enhanced recovery after surgery (ERAS) protocol for patients with primary peritoneal carcinomatosis (PC) undergoing cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (HIPEC) based ...
Tkachenko, O. I.   +12 more
core   +1 more source

Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer [PDF]

open access: yes, 2021
Ovarian cancer is known as the second most common cause of death among gynecologic cancers. Survival outcome has been reported to be significantly associated with the efforts to minimize residual disease after cytoreductive surgery.
Chang, SJ, Son, JH
core   +1 more source

Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]

open access: yesKorean Journal of Anesthesiology, 2021
Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás   +7 more
doaj   +1 more source

ASO author reflections: secondary cytoreductive surgery in recurrent ovarian cancer

open access: yes, 2020
Secondary Cytoreductive Surgery in Recurrent Ovarian ...
Marchetti C.   +7 more
core   +1 more source

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

open access: yesWorld Journal of Surgical Oncology, 2019
Background Standard treatment for colorectal peritoneal carcinomatosis typically involves cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and if possible, postoperative adjuvant chemotherapy. However, a substantial percentage of
M. Leimkühler   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy